Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Eicke Latz recalls the discovery of the inflammasome in 2002 and how it revolutionized our understanding of inflammation and is now a target of new immunotherapeutics for inflammatory disease.
Mihai Netea tells us how the dichotomy of innate and adaptive immunity was blurred with the description of trained immunity in 2012 — a process by which innate immune cells and their progenitors store memory of past infections by epigenetic reprogramming.
As we celebrate 20 years since the launch of Nature Reviews Immunology, we reflect on how far the field of immunology has advanced over the past two decades.
Beth Stevens and Matthew Johnson discuss the unexpected finding that classical complement components guide synaptic pruning in the brain and are necessary for healthy brain function.
A new study explores the links between diet and colorectal cancer risk by showing that changes to the intestinal microbiome in mice fed a high-fat diet result in attenuated MHC class II expression by intestinal stem cells and hence impaired immune surveillance of tumour initiation.
Muhammad Suleman Rana and colleagues from the National Institute of Health in Pakistan discuss the urgent need to implement catch-up vaccination programmes for measles and polio to prevent resurgence of these deadly diseases.
This Comment article proposes that T cell-oriented vaccine strategies should be considered to control the COVID-19 pandemic in the longer term, given declining levels of neutralizing antibodies with time after vaccination or infection and the emergence of viral escape variants.
A new study describes the extensive transcriptional remodelling that occurs in neutrophils during inflammation, detailing the transcription factors that control neutrophil maturation and effector functions.
It took roughly 1 year for a COVID-19 vaccine to become available, yet, four decades after the first patient with HIV was described, we do not yet have a vaccine for HIV. Here, Barton Haynes examines the biological reasons why vaccine development for HIV is so exceptionally challenging.